Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹230 Cr | ₹1282 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | 2.92% | 3.95% |
6 Month | 6.83% | 7.58% |
1 Year | 9.37% | 9.88% |
3 Year | 22.5% | 24.31% |
5 Year | - | 21.03% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | 6.17% | 7.46% |
1 Year | 6.47% | 9.63% |
3 Year | 23.21% | 25.05% |
5 Year | - | 20.35% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 20.48% | 9.47% |
3 Year | 18.71% | 18.04% |
5 Year | - | 14.89% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.42% | 15.93% |
Sharp | 1.06% | 1.09% |
Beta | 0.95% | 0.99% |
Alpha | -1.54% | -1.23% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Funds Managed | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 3.93 | 10.06 |
Mid Cap | 35.23 | 32.77 |
Small Cap | 33.57 | 29.61 |
Large Cap | 27.27 | 27.56 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 2.74 | 7.68 |
Healthcare | 92.05 | 89.02 |
Basic Materials | 4.2 | 2.34 |
Industrials | 1.01 | - |
Financial Services | - | 0.96 |
Top Comparisons
Aditya Birla Sun Life Gold Fund-Growth
3Y Returns22.63%
LIC MF Gold ETF Fund of Fund -Regular Plan-Growth
3Y Returns23.16%
ICICI Prudential MidCap Fund - Growth
3Y Returns23.11%
HSBC Midcap Fund - Regular Growth
3Y Returns24.08%
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
3Y Returns28.01%
Axis Global Equity Alpha Fund of Fund - Regular Plan - Growth Option
3Y Returns18.6%
ITI Small Cap Fund Regular - Growth
3Y Returns28.99%
Nippon India Small Cap Fund - Growth Plan - Bonus Option
3Y Returns27.3%